Negrin RS - Search Results

1

Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.

Schriber JR, Chao NJ, Long GD, Negrin RS, Tierney DK, Kusnierz-Glaz C, Lucas KS, Blume KG. Schriber JR, et al. Among authors: negrin rs. Blood. 1994 Sep 1;84(5):1680-4. Blood. 1994. PMID: 7520782 Free article. Clinical Trial.

2

G-CSF and peripheral blood progenitor cells.

Chao NJ, Long GD, Negrin RS, Schriber JR, Raimondi CM, Brown SL, Blume KG. Chao NJ, et al. Among authors: negrin rs. Lancet. 1992 Jun 6;339(8806):1410. Lancet. 1992. PMID: 1375969 Clinical Trial. No abstract available.

3

The use of colony stimulating factors in clinical bone marrow transplantation.

Negrin RS, Greenberg PL. Negrin RS, et al. Curr Opin Immunol. 1992 Oct;4(5):567-70. doi: 10.1016/0952-7915(92)90027-c. Curr Opin Immunol. 1992. PMID: 1418720 Review.

4

Dynamic assessment of quality of life after autologous bone marrow transplantation.

Chao NJ, Tierney DK, Bloom JR, Long GD, Barr TA, Stallbaum BA, Wong RM, Negrin RS, Horning SJ, Blume KG. Chao NJ, et al. Among authors: negrin rs. Blood. 1992 Aug 1;80(3):825-30. Blood. 1992. PMID: 1638031 Free article.

5

Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.

Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P. Nagler A, et al. Leukemia. 1990 Mar;4(3):193-202. Leukemia. 1990. PMID: 1690318

6

Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.

Greenberg P, Negrin R, Nagler A, Vincent M, Donlon T. Greenberg P, et al. Int J Cell Cloning. 1990 Jan;8 Suppl 1:293-300; discussion 300-2. doi: 10.1002/stem.5530080728. Int J Cell Cloning. 1990. PMID: 1691248 Free article.

7

Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.

Greenberg P, Negrin R, Nagler A, Souza L, Donlon T. Greenberg P, et al. Prog Clin Biol Res. 1990;338:151-61. Prog Clin Biol Res. 1990. PMID: 1693211 No abstract available.

8

Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor.

Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL. Negrin RS, et al. Blood. 1990 Jul 1;76(1):36-43. Blood. 1990. PMID: 1694702 Free article.

9

Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF.

Nagler A, Binet C, Mackichan ML, Negrin R, Bangs C, Donlon T, Greenberg P. Nagler A, et al. Blood. 1990 Oct 1;76(7):1299-307. Blood. 1990. PMID: 1698477 Free article.

10

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL. Schmidt-Wolf IG, et al. Among authors: negrin rs. J Exp Med. 1991 Jul 1;174(1):139-49. doi: 10.1084/jem.174.1.139. J Exp Med. 1991. PMID: 1711560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters